Legal Advantage Investments’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-4,995
Closed -$1.63M 107
2024
Q1
$1.63M Hold
4,995
0.91% 37
2023
Q4
$952K Buy
4,995
+25
+0.5% +$4.72K 0.57% 49
2023
Q3
$990K Buy
4,970
+1,350
+37% +$319K 0.71% 42
2023
Q2
$1.03M Buy
+3,620
New +$1.01M 0.69% 43

Other funds holding SWAV

Legal Advantage Investments's SWAV Position: Q2 2024 in Review

Legal Advantage Investments sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 4,995 shares — an estimated $1.63M sold.

Legal Advantage Investments first reported a position in SWAV in Q2 2023 and held it in 4 quarters. The position peaked at $1.63M in Q1 2024. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Legal Advantage Investments reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Legal Advantage Investments sold 4,995 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $1.63M.
  • Legal Advantage Investments first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2023 and held it in 4 quarters.
  • Legal Advantage Investments's Shockwave Medical, Inc. Common Stock position peaked at $1.63M in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Legal Advantage Investments's 13F filing for Q2 2024, filed 11 Jul 2024.